107 completed, 10 terminated, 8 active not recruiting, 8 unknown. 149 Phase 1, 29 Phase 2.
Follow Acetaminophen: new trials by email Literature Review of Acetaminophen trials Research Report on Acetaminophen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001) MK-6255, CD8 PET Tracer, Acetaminophen - Ovarian Neoplasms, Endometrial Neoplasms | Phase 1 | Not yet recruiting | Merck Sharp & Dohme LLC | 80 | 2026-11-13 | 2026-11-16 |
| Preoperative Celecoxib and Acetaminophen Versus Acetaminophen Alone for Pain Control After Pediatric Adenotonsillectomy Celecoxib, Acetaminophen, Dexamethasone - Adenotonsillectomy, Postoperative Pain | Phase 1 / Phase 2 | Not yet recruiting | NYU Langone Health | 500 | 2026-11-01 | 2026-10-13 |
| A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weight Semaglutide, Placebo semaglutide, Paracetamol - Obesity, Overweight | Phase 1 | Not yet recruiting | Novo Nordisk A/S | 60 | 2026-09-25 | 2026-09-29 |
| A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity Tirzepatide, Acetaminophen, Placebo - Diabetes Mellitus, Type 1, Overweight | Phase 1 | Recruiting | Eli Lilly and Company | 18 | 2026-09-11 | 2026-09-23 |
| Post-Vasectomy Pain Study Acetaminophen, ibuprofen, oxycodone - Vasectomy, NSAIDs | Phase 1 | Recruiting | Columbia University | 200 | 2026-09-10 | 2026-09-24 |
| A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight Eloralintide, Placebo, Acetaminophen - Obesity, Overweight | Phase 1 | Recruiting | Eli Lilly and Company | 56 | 2026-07-31 | 2026-08-20 |
| A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant UBT251, Oral contraceptive, Acetaminophen - Overweight, Obesity | Phase 1 | Recruiting | Novo Nordisk A/S | 40 | 2026-07-17 | 2026-08-25 |
| Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin Acetaminophen, Metformin, Warfarin - Overweight, Obesity | Phase 1 | Not yet recruiting | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 42 | 2026-04-08 | 2026-03-30 |
| A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight NNC0662-0419, Oral contraceptive, Acetaminophen - Overweight, Obesity | Phase 1 | Active not recruiting | Novo Nordisk A/S | 41 | 2026-04-07 | 2026-09-30 |
| A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity PF-08653944, Acetaminophen - Obesity, Overweight and/or Obesity | Phase 1 | Active not recruiting | Pfizer | 22 | 2026-03-31 | 2026-07-09 |
| A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects HRS-7535 Tablets, Paracetamol Tablets, Digoxin Tablets - Obesity, Overweight | Phase 1 | Completed | Shandong Suncadia Medicine Co., Ltd. | 40 | 2025-12-07 | 2026-06-29 |
| A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity AZD6234, Ethinyl estradiol/Levonorgestrel (EE/LEVO), Acetaminophen (APAP) - Healthy Participants | Phase 1 | Active not recruiting | AstraZeneca | 100 | 2025-06-04 | 2026-10-13 |
| A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants BMS-986446 IV, BMS-986446 SC, Acetaminophen - Healthy Volunteer | Phase 1 | Completed | Bristol-Myers Squibb | 46 | 2025-05-05 | 2025-10-01 |
| The Effect of AMG 133 on Gastric Emptying AMG 133, Placebo, Acetaminophen - Overweight or Obesity | Phase 1 | Completed | Amgen | 57 | 2025-04-17 | 2026-02-24 |
| A Study of BGM0504 in Overweight or Obese Participants Paracetamol, Metformin Hydrochloride, Warfarin - Overweight or Obese | Phase 1 | Completed | BrightGene Bio-Medical Technology Co., Ltd. | 28 | 2025-03-25 | 2026-10-13 |
| A Randomized Clinical Trial of the Effectiveness of Acupressure in Relieving Orthodontic Pain Acetaminophen, Acupressure - Orthodontic Pain (D013850), Pain Management (D016146) | Phase 1 | Not yet recruiting | University of Baghdad | 56 | 2025-02-10 | 2025-02-10 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy Subjects HRS-4729 injection, HRS-4729 injection placebo, HRS9531 injection - Overweight or Obesity | Phase 1 | Completed | Fujian Shengdi Pharmaceutical Co., Ltd. | 102 | 2025-01-16 | 2026-04-30 |
| Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects Acetaminophen, Metformin, Warfarin - Type 2 Diabetes | Phase 1 | Completed | Fujian Shengdi Pharmaceutical Co., Ltd. | 57 | 2024-12-18 | 2025-06-22 |
| Patient Controlled Administration of Liquid Acetaminophen Acetaminophen 650 mg Oral Tablet, Acetaminophen 650mg Liquid, CADD pump - Pain, Pain, Postoperative | Phase 1 | Completed | Yale University | 24 | 2024-11-19 | 2026-08-06 |
| Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants Pentavalent Meningococcal ABCYW vaccine, MenACYW conjugate vaccine, Meningococcal group B vaccine - Meningococcal Immunization, Healthy Volunteers | Phase 1 / Phase 2 | Active not recruiting | Sanofi Pasteur, a Sanofi Company | 750 | 2024-11-05 | 2026-01-20 |
Showing 20 of 149. Sign in to see all of them.
Obesity (17) · Overweight (16) · Pain (11) · Pain, Postoperative (10) · Agnosia (8) · Diabetes Mellitus, Type 2 (5) · Lymphoma, Non-Hodgkin (5) · Ductus Arteriosus, Patent (4) · Osteoarthritis (4) · Acute Pain (3) · Burkitt Lymphoma (3) · Fever (3) · Hodgkin Disease (3) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (3) · Lymphoma (3)
National Cancer Institute (NCI) (14) · University Hospital, Clermont-Ferrand (8) · Novo Nordisk A/S (7) · GlaxoSmithKline (6) · Merck Sharp & Dohme LLC (5) · Eli Lilly and Company (4) · AstraZeneca (3) · Boehringer Ingelheim (3) · Janssen Korea, Ltd., Korea (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · University Medicine Greifswald (3) · Bayer (2) · Baylor College of Medicine (2) · Daewon Pharmaceutical Co., Ltd. (2) · David Chi, MD (2)
United States (70) · France (12) · Germany (10) · China (9) · Canada (7) · South Korea (6) · Spain (6) · United Kingdom (5) · Denmark (4) · Finland (4) · Brazil (3) · Egypt (3) · Italy (3) · Mexico (3) · Taiwan (3)
David H Chi, MD (2) · James L Gulley, M.D. (2) · Jeffrey Bluestone, PhD (2)
PMID 17397460, PMID 19217726, PMID 20934693, PMID 21300401, PMID 21340616, PMID 21518322, PMID 21792552, PMID 23415783, PMID 23551925, PMID 24030379, PMID 25734008, PMID 26225223, PMID 26229445, PMID 26951240, PMID 28630120, PMID 28637662, PMID 28752679, PMID 29274831, PMID 29667449, PMID 30227893, PMID 30471141, PMID 30908574, PMID 31113777, PMID 32078124, PMID 32416981, PMID 32702298, PMID 33078388, PMID 33112184, PMID 33306989, PMID 33335322, PMID 33558725, PMID 33602696, PMID 33617777, PMID 33713216, PMID 33907224, PMID 34280257, PMID 34480858, PMID 34687939, PMID 34889384, PMID 35135601, PMID 35170228, PMID 35410754, PMID 35605184, PMID 35622074, PMID 35800670, PMID 35819312, PMID 35876974, PMID 36322627, PMID 36882409, PMID 37138460
2023 (3), 2009 (2), 2014 (1), 2015 (1), 2018 (1), 2019 (1), P30CA033572 (1), R34AI095135 (1), U01AI110658 (1)